| 1 |
Zeng J, Li X, Sander M, Zhang H, Yan G, Lin Y. Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas. Front Immunol 2021;12:721830. [PMID: 34675919 DOI: 10.3389/fimmu.2021.721830] [Reference Citation Analysis]
|
| 2 |
Yamashita M, Tasaki M, Murakami R, Arai Y, Nakamura T, Nakao S. Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression. Mol Ther Oncolytics 2021;20:422-32. [PMID: 33665362 DOI: 10.1016/j.omto.2021.01.016] [Reference Citation Analysis]
|
| 3 |
Kurosaki H, Nakatake M, Sakamoto T, Kuwano N, Yamane M, Ishii K, Fujiwara Y, Nakamura T. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice. Cells 2021;10:985. [PMID: 33922406 DOI: 10.3390/cells10050985] [Reference Citation Analysis]
|
| 4 |
Bhatt DK, Chammas R, Daemen T. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis. Vaccines (Basel) 2021;9:1166. [PMID: 34696274 DOI: 10.3390/vaccines9101166] [Reference Citation Analysis]
|
| 5 |
Nakatake M, Kuwano N, Kaitsurumaru E, Kurosaki H, Nakamura T. Fusogenic oncolytic vaccinia virus enhances systemic antitumor immune response by modulating the tumor microenvironment. Mol Ther 2021;29:1782-93. [PMID: 33348052 DOI: 10.1016/j.ymthe.2020.12.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Shin J, Hong SO, Kim M, Lee H, Choi H, Kim J, Hong J, Kang H, Lee E, Lee S, Kong B, Kim M, Choi H, Kim S. Generation of a Novel Oncolytic Vaccinia Virus Using the IHD-W Strain. Hum Gene Ther 2021;32:517-27. [PMID: 32854548 DOI: 10.1089/hum.2020.050] [Reference Citation Analysis]
|
| 7 |
Matsugo H, Kitamura-Kobayashi T, Kamiki H, Ishida H, Sekine W, Takenaka-Uema A, Nakagawa T, Murakami S, Horimoto T. A potential bat adenovirus-based oncolytic virus targeting canine cancers. Sci Rep 2021;11:16706. [PMID: 34408176 DOI: 10.1038/s41598-021-96101-4] [Reference Citation Analysis]
|
| 8 |
Zhang Z, Dong L, Zhao C, Zheng P, Zhang X, Xu J. Vaccinia virus-based vector against infectious diseases and tumors. Hum Vaccin Immunother 2021;17:1578-85. [PMID: 33606578 DOI: 10.1080/21645515.2020.1840887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 9 |
Wu TM, Liu JB, Liu Y, Shi Y, Li W, Wang GR, Ma YS, Fu D. Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control. Cancer Control 2020;27:1073274820934805. [PMID: 32806937 DOI: 10.1177/1073274820934805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Kaygisiz K, Synatschke CV. Materials promoting viral gene delivery. Biomater Sci 2020;8:6113-56. [PMID: 33025967 DOI: 10.1039/d0bm01367f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
|
